Dr. Bhutani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
595 Buckingham Way
Ste 220
San Francisco, CA 94132Phone+1 415-333-0348
Summary
- Dr. Tina Bhutani is a board certified dermatologist and clinical researcher practicing in San Francisco, California where she is the CEO of Synergy Dermatology. She received her medical training at the University of Southern California Keck School of Medicine and completed her residency in dermatology at UCSF. Dr. Bhutani has an expertise in the treatment of psoriasis, atopic dermatitis, and other inflammatory skin diseases. In addition to seeing patients, she is an Associate Clinical Professor in the Department of Dermatology at UCSF. She is passionate about improving the care and lives of patients with inflammatory skin disorders and is involved in many studies focusing on the development of new treatments for these diseases and learning more about mechanisms of disease initiation and maintenance. She has a particular interest in the impact of disease on patient quality of life and mental health as well as the use of wellness-based behavior modification to improve disease severity and reduce the risk of associated comorbidities. She has published over 150 articles in peer-reviewed journals and has spoken at national and international conferences on these topics. She is a member of the National Psoriasis Foundation (NPF) Scientific Advisory committee and Medical Advisory Board. She has also received research grant funding from the NPF, the Dermatology Foundation, as well as Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). She serves as the current editor-in-chief for the journal Psoriasis: Targets and Therapy.
Education & Training
- University of California (San Francisco)Chief Residency, Dermatology, 2014 - 2015
- University of California (San Francisco)Residency, Dermatology, 2012 - 2015
- University of California (San Diego) Medical CenterInternship, Preliminary Year, 2008 - 2009
- Keck School of Medicine of the University of Southern CaliforniaClass of 2008
- University of CaliforniaBS, Animal Physiology & Neuroscience, 2004
Certifications & Licensure
- CA State Medical License 2009 - 2026
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- National Psoriasis Foundation Medical Dermatology Research Grant Recipient 2012
- Dean’s Recognition Keck School of Medicine, 2008
- Scholarship for Academic Excellence Keck School of Medicine, 2008
- Join now to see all
Clinical Trials
- Safety and Efficacy Study of Combination Treatment With Excimer Laser, Clobex Spray, and Vectical Ointment in the Treatment of Psoriasis Start of enrollment: 2010 Jun 01
- The Quality of Life Study in Psoriasis Patients After Ustekinumab Treatment Start of enrollment: 2012 Mar 01
- Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Start of enrollment: 2017 Mar 28
- Join now to see all
Publications & Presentations
PubMed
- A case of a patient with erythema annulare centrifugum found to have aggressive fibromatosis.Kathryn Haran, Allison Kranyak, Chandler E Johnson, Payton L Smith, Stephanie Hunt
JAAD Case Reports. 2025-01-01 - Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus Statement.Yagiz Matthew Akiska, Paradi Mirmirani, Ingrid Roseborough, Erin Mathes, Tina Bhutani
JAMA Dermatology. 2025-01-01 - 1 citationsThe Association of Interleukin-36 Staining Intensity and Response to Biologic Therapy in Patients With Psoriasis: A Retrospective Immunohistochemical and Chart Review ...William R Zhang, Tina Bhutani, Jeffrey P North
Journal of Cutaneous Pathology. 2025-01-01
Journal Articles
- The Impact of Pediatric Atopic Dermatitis on Families: A ReviewJohn Koo, Tina Bhutani, Pediatric Dermatology
- Dupilumab Treatment for Generalized Prurigo NodularisTina Bhutani, Wilson Liao, JAMA
- Recent Developments in Atopic DermatitisSahil Sekhon, Tina Bhutani, AAP News
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Safe and Effective Treatment of Moderate to Severe Psoriasis using 308nm Excimer Laser, Clobetasol Spray, and Calcitriol Ointment.Bhutani T, The Photomedicine Society 20th Annual Meeting, New Orleans, LA
- Anatomically Differentiated Dosimetry for Optimal Phototherapy of Generalized Psoriasis.Bhutani T, The American Academy of Dermatology Summer Academy Meeting 2011., New York, New York
- Innovative Treatment Option for Moderate-to-Severe Generalized Plaque Psoriasis Using 308nm-UVB Excimer Laser, Clobetasol Spray, and Calcitriol Ointment.Heller MM, Lee ES, Kamangar F, Park K, Bhutani T, and Koo JYM, European Society for Dermatological Research’s 41st Annual Meeting, Barcelona, Spain
- Join now to see all
Lectures
- PhototherapyAmerican Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019
- A Pilot Study Evaluating the Efficacy of Intra-Lesional Amevive.Tokyo, Japan. Astellas Headquarters
- Modern Ultra Goeckerman Therapy.Kasturba Medical College, Manipal, India
Other
- Keratosis Follicularis (Darier Disease).Kwok P, Bhutani T, Liao W, eMedicine from WebMD
http://emedicine.medscape.com/article/1107340-overview.
Authored Content
- Recent Developments in Atopic DermatitisSeptember 2018
Press Mentions
- Megan Mosca on the Impact of Systemic Psoriasis Tx on Cardiometabolic ComorbiditiesDecember 17th, 2021
- STRATA Skin Sciences's (SSKN) CEO Dr. Dolev Rafaeli on Q1 2020 Results - Earnings Call TranscriptMay 12th, 2020
- Luma Therapeutics Announces Positive Clinical Data for the Illuvinate System, a New in-Home Treatment for PsoriasisMarch 6th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: